BLOT5 Antibody

What is the fundamental principle behind Western blot antibody detection?

Western blotting is a powerful analytical technique used to detect specific proteins in a complex mixture of proteins extracted from cells. The process involves three key elements: (1) separation of proteins by size using gel electrophoresis, (2) transfer of these proteins to a solid support membrane, and (3) visualization of the target protein using specific antibodies. The technique relies on the specificity of antibody-antigen interactions, where primary antibodies bind to target proteins and secondary antibodies conjugated with detectable labels (such as HRP) bind to the primary antibodies. When substrate is added, the enzyme reaction produces a detectable signal proportional to the amount of target protein present . This methodology creates a characteristic "blot" pattern that allows for both qualitative identification and quantitative measurement of specific proteins.

How should I determine the appropriate antibody dilution for Western blot experiments?

Determining the optimal antibody dilution is critical for balancing sensitivity and specificity in Western blot experiments. A systematic approach involves:

• Performing an antibody titration experiment using a pooled sample

• Creating a dilution series (typically 1:500, 1:1000, 1:2000, 1:5000, and 1:10,000)

• Analyzing densitometric data to identify the linear dynamic range

• Selecting a dilution in the middle of this linear range for experimental use

What are the most appropriate controls for validating antibody specificity in Western blots?

Proper controls are essential for validating antibody specificity. Based on consensus recommendations from the International Working Group for Antibody Validation, researchers should implement multiple validation strategies:

• Genetic controls: Using knockout or knockdown samples as negative controls to confirm specificity

• Peptide blocking: Preincubating antibody with corresponding peptide to demonstrate binding specificity

• Multiple antibody verification: Using independent antibodies targeting different epitopes of the same protein

• Recombinant expression: Overexpressing the target protein as a positive control

• Immunoprecipitation-MS: Confirming identity of captured proteins via mass spectrometry

For example, a properly controlled Western blot experiment with anti-CX3CR1 antibody would include untreated sample (showing specific binding) and peptide-blocked control (showing absence of signal), as demonstrated in the literature . Additionally, positive controls should utilize cell lines known to express the target protein, such as Jurkat cells for human UBR5 detection . These comprehensive controls ensure experimental rigor and reproducibility in antibody-based research .

How can I optimize Western blot conditions for high molecular weight proteins like UBR5?

High molecular weight proteins like UBR5 (~300 kDa) present unique challenges for detection by Western blot. Optimization requires:

• Gel selection: Use 3-8% Tris-Acetate gels specifically designed for proteins >200 kDa

• Transfer conditions: Employ extended transfer times (12-16 hours) at low voltage or specialized rapid high molecular weight transfer protocols

• Buffer composition: Use SDS-containing transfer buffers to maintain protein solubility

• Blocking optimization: Test both BSA and non-fat milk as blocking agents (BSA often preferred for phospho-specific antibodies)

• Antibody selection: Choose antibodies validated specifically for high molecular weight targets

When working with UBR5 antibody, Western blot data from Jurkat human acute T cell leukemia cell line, HT-2 mouse T cell line, and rat ovary tissue demonstrates successful detection at approximately 300 kDa using 0.5 µg/mL of sheep anti-human/mouse/rat UBR5 antibody followed by HRP-conjugated secondary antibody . These experiments were conducted under reducing conditions using specific immunoblot buffer systems optimized for high molecular weight proteins.

What methodological approaches ensure quantitative reliability in Western blot experiments?

Achieving quantitative reliability in Western blot experiments requires rigorous methodological controls:

The critical step is determining the appropriate protein load that corresponds to the middle of the linear dynamic range for each antibody. This often requires dilution of individual samples to different extents for different antibodies to ensure all measurements fall within the quantitative range. For example, research demonstrates that loading samples above 10 μg protein can exceed the linear dynamic range for many antibodies, resulting in signal saturation and false negatives when comparing experimental conditions . Modern approaches using stain-free gel technology for total protein normalization can significantly improve quantitative accuracy compared to traditional housekeeping protein normalization .

How should researchers interpret unexpected molecular weight variations when detecting STAT5 proteins?

When encountering unexpected molecular weight variations in STAT5 detection, researchers should consider several biological and technical factors:

• Post-translational modifications: Phosphorylation, ubiquitination, or SUMOylation can increase apparent molecular weight

• Alternative splicing: STAT5 genes may produce multiple isoforms with different molecular weights

• Proteolytic processing: Sample preparation conditions may cause partial degradation

• Experimental conditions: Reducing vs. non-reducing conditions affect protein migration

• Gel percentage and buffer system: Different electrophoresis systems can alter migration patterns

STAT5b typically appears at approximately 90 kDa on Western blots , but variations may occur across different experimental systems. When encountering unexpected bands, researchers should perform validation experiments using stimulation conditions known to activate STAT5 (like cytokine treatment), use paired antibodies recognizing different epitopes, and include appropriate positive and negative controls. Additionally, immunoprecipitation followed by mass spectrometry can definitively identify unexpected bands to distinguish between true isoforms and non-specific binding .

What are the most common causes of high background in Western blots, and how can they be systematically addressed?

High background in Western blots can significantly impact data interpretation. Systematic troubleshooting should address:

• Blocking inefficiency:

  • Problem: Insufficient blocking allows non-specific antibody binding

  • Solution: Optimize blocking agent concentration (5% BSA or non-fat milk) and duration (1-2 hours at room temperature or overnight at 4°C)

• Antibody concentration:

  • Problem: Excessive primary or secondary antibody

  • Solution: Perform titration experiments to determine optimal dilution within linear dynamic range

• Buffer composition:

  • Problem: Insufficient washing or detergent concentration

  • Solution: Increase washing steps (minimum 4-5 washes of 5-10 minutes each) and optimize detergent concentration

• Membrane handling:

  • Problem: Membrane drying or contamination

  • Solution: Maintain membrane hydration throughout procedure and use clean containers/reagents

• Detection system sensitivity:

  • Problem: Overly sensitive substrate for chemiluminescent detection

  • Solution: Dilute substrate or reduce exposure time during imaging

For phospho-specific antibodies, BSA is generally preferred over milk for blocking, as milk contains casein which is a phosphoprotein and may interfere with detection . Additionally, for STAT5 and related signaling proteins, thorough membrane washing with TBST (minimum 4 three-minute wash steps between incubations) has been shown to significantly reduce background while maintaining specific signal .

How can researchers resolve antibody cross-reactivity issues between closely related proteins like STAT5a and STAT5b?

Resolving cross-reactivity between highly homologous proteins like STAT5a and STAT5b requires careful antibody selection and experimental design:

• Epitope selection: Choose antibodies targeting unique regions rather than conserved domains

• Validation with recombinant proteins: Test antibodies against purified recombinant STAT5a and STAT5b proteins

• Genetic validation: Use STAT5a or STAT5b knockout/knockdown samples as controls

• Immunoprecipitation approach: Pull down with isoform-specific antibody followed by Western blot

• Peptide competition: Use blocking peptides specific to each isoform to confirm specificity

For example, when using Stat5b antibody (#34662), researchers should note it's derived from a synthetic peptide corresponding to residues near the carboxy terminus of human Stat5b protein , a region that differs from STAT5a. Specificity can be further validated by immunoprecipitation experiments, where the antibody should selectively pull down the target protein at the expected molecular weight (90 kDa for STAT5b) . When cross-reactivity cannot be eliminated, researchers may need to use complementary techniques like mass spectrometry to definitively identify which isoform is present in their samples .

What strategies can address the challenges of detecting low-abundance proteins in complex biological samples?

Detecting low-abundance proteins requires specialized approaches to enhance sensitivity while maintaining specificity:

• Sample enrichment techniques:

  • Subcellular fractionation to concentrate proteins from relevant compartments

  • Immunoprecipitation to concentrate target proteins before Western blotting

  • Phospho-enrichment using TiO₂ or immobilized metal affinity chromatography for phosphoproteins

• Signal amplification methods:

  • Enhanced chemiluminescence (ECL) substrates with extended signal duration

  • Fluorescent secondary antibodies with multiple fluorophores per antibody

  • Tyramide signal amplification (TSA) for enzymatic signal enhancement

• Optimized detection parameters:

  • High-sensitivity CCD camera systems with cooling capabilities

  • Extended exposure times with low background detection systems

  • Digital image integration to enhance signal while controlling background

• Experimental controls:

  • Include positive control samples with known expression of target protein

  • Use recombinant protein standards for absolute quantification

  • Employ spike-in controls to verify detection sensitivity

For transcription factors like STAT5b that may be present at low levels in certain cell types, researchers should consider cell treatment with appropriate cytokines to induce expression and phosphorylation prior to Western blot analysis . Additionally, selecting antibodies with demonstrated sensitivity for the specific application and optimizing protein loading within the linear dynamic range is critical for successful detection of low-abundance targets .

How does antibody source (monoclonal vs. polyclonal vs. recombinant) impact Western blot experimental design and interpretation?

Antibody source significantly impacts experimental design and data interpretation in Western blotting:

Recent studies have demonstrated that recombinant antibodies outperform both monoclonal and polyclonal antibodies in Western blot applications . The YCharOS group's analysis of 614 antibodies revealed that recombinant antibodies provided superior performance across multiple assays, with reduced batch variability . For critical applications requiring high reproducibility, researchers should consider recombinant antibodies when available. For instance, when studying STAT5 in longitudinal studies or multi-center collaborations, recombinant antibodies offer significant advantages in ensuring consistent results across time and laboratories .

What minimum validation standards should researchers apply before using commercial antibodies in published research?

Based on current consensus guidelines, researchers should implement these minimum validation standards:

• Literature verification: Review existing publications using the same antibody lot/clone

• Multi-assay validation: Verify antibody performance in the specific application (Western blot, IHC, etc.)

• Genetic controls: Test antibody against knockout/knockdown samples when available

• Orthogonal validation: Confirm results using antibody-independent methods (e.g., mass spectrometry)

• Multiple antibody approach: Verify findings using independent antibodies targeting different epitopes

Research indicates that ~50% of commercial antibodies fail to meet basic characterization standards, resulting in estimated financial losses of $0.4–1.8 billion annually in the United States alone . To address this, the International Working Group for Antibody Validation established the "five pillars" of antibody characterization (genetic, orthogonal, multiple antibody, recombinant expression, and immunocapture-MS strategies) . While not all five strategies are required for every antibody, researchers should implement as many as feasible to ensure rigorous validation before publication.

How should researchers address and report contradictory Western blot data when using different antibodies against the same target?

When confronted with contradictory Western blot data from different antibodies targeting the same protein, researchers should:

• Critically evaluate antibody validation: Review validation data for each antibody, including epitope information, validation methods, and positive/negative controls

• Consider biological complexity:

  • Different antibodies may recognize different protein isoforms

  • Post-translational modifications might mask epitopes for certain antibodies

  • Protein complexes may affect epitope accessibility

• Perform additional validation experiments:

  • Genetic approaches (siRNA, CRISPR) to confirm specificity

  • Immunoprecipitation followed by mass spectrometry

  • Peptide competition assays to confirm epitope specificity

• Transparent reporting:

  • Document all antibodies used (source, catalog number, lot, dilution)

  • Describe all validation experiments performed

  • Present contradictory results rather than selectively reporting

  • Discuss potential biological explanations for discrepancies

A recent study found that an average of ~12 publications per protein target included data from antibodies that failed to recognize the relevant target protein . This underscores the importance of rigorous validation and transparent reporting. When discrepancies cannot be resolved, researchers should acknowledge limitations and consider complementary techniques like mass spectrometry for definitive protein identification.

What are the current best practices for multiplexed detection of STAT family proteins in the same Western blot?

Multiplexed detection of STAT family proteins requires careful experimental design:

• Strategic antibody selection:

  • Choose primary antibodies from different host species (e.g., rabbit anti-STAT5a, goat anti-STAT5b)

  • Select antibodies recognizing distinct molecular weight targets when from same species

  • Verify no cross-reactivity between secondary antibodies

• Technical approaches:

  • Sequential immunodetection with stripping between each target

  • Fluorescent multiplexing using differentially labeled secondary antibodies

  • Size-based multiplexing for distinctly sized targets

• Control experiments:

  • Single-antibody controls to confirm band identity

  • Phospho/total protein pairs to assess activation status

  • Positive control samples with known expression patterns

When detecting multiple STAT family members, researchers should be aware that traditional stripping and reprobing can cause protein loss from membranes (up to 10-20% per stripping cycle), potentially compromising quantitative analysis . Fluorescent multiplexing using different wavelength secondary antibodies offers advantages for quantitative applications, allowing simultaneous detection without stripping. For STAT5a/b discrimination, antibodies targeting the distinct C-terminal regions provide the highest specificity for differentiating these highly homologous proteins .

How can quantitative Western blot data be integrated with other -omics approaches for systems biology analysis?

Integrating quantitative Western blot data with other -omics approaches requires strategic experimental design and data analysis:

• Experimental planning:

  • Collect matched samples for parallel -omics analyses

  • Include calibration standards for absolute quantification

  • Design time-course experiments to capture dynamic changes

• Data normalization approaches:

  • Employ global normalization strategies compatible across platforms

  • Use spike-in standards for cross-platform calibration

  • Apply appropriate statistical methods for heterogeneous data integration

• Integration methodologies:

  • Correlation analysis between protein levels and mRNA expression

  • Pathway mapping incorporating phosphorylation data

  • Network analysis integrating protein-protein interaction data

• Validation strategies:

  • Confirm key findings with orthogonal techniques

  • Perform perturbation experiments to test model predictions

  • Use targeted approaches to verify system-wide observations

For STAT signaling pathways, integration of Western blot phosphorylation data with RNA-seq transcriptional profiles can reveal the functional consequences of signaling events. For example, quantitative analysis of STAT5 phosphorylation by Western blot can be correlated with expression changes in STAT5 target genes to establish causality in signaling networks. Researchers should normalize Western blot data using appropriate methods (preferably total protein normalization) to ensure accurate quantification before integration with other data types .

What specialized approaches enable detection of post-translational modifications in STAT proteins by Western blot?

Detection of post-translational modifications (PTMs) in STAT proteins requires specialized approaches:

• Phosphorylation detection:

  • Use phospho-specific antibodies targeting specific residues (e.g., pY694 for STAT5)

  • Include phosphatase inhibitors in lysis buffers to preserve modification

  • Use positive control samples with stimulation conditions known to induce phosphorylation

• Other PTMs (ubiquitination, acetylation, SUMOylation):

  • Include specific PTM inhibitors during sample preparation

  • Use high-percentage gels to resolve small mobility shifts

  • Consider immunoprecipitation to enrich modified forms before Western blot

• Sample treatment considerations:

  • Rapid sample processing to preserve labile modifications

  • Appropriate stimulation conditions to induce modifications

  • Subcellular fractionation to enrich modified proteins in relevant compartments

• Controls and validation:

  • Treatment with phosphatases or deubiquitinases as negative controls

  • Use of PTM-inducing agents as positive controls

  • Validate key findings with mass spectrometry

For STAT5 phosphorylation studies, researchers should note that "detection of post-translationally modified proteins may require specific treatments" . Cell Signaling Technology's resources indicate that cytokine stimulation protocols can effectively induce STAT5 phosphorylation in specific cell models. Additionally, the PhosphoSitePlus® database provides valuable information about known modified residues on STAT proteins, their functional significance, and validated treatments that modulate these modifications in specific experimental systems .